News and commentary from the psychiatry world
— News and commentary from the psychiatry world
June 17, 2026
• 1 min read
The FDA cleared Wave Neuroscience's biomarker-guided neuromodulation system (MeRT) to treat post-traumatic stress disorder (PTSD), the company announced.
Gastrointestinal interoception was disrupted across multiple domains in a study of weight-restored women with anorexia nervosa, with several interoceptive markers tied to relapse risk. (JAMA Psychiatry)
Wave Neuroscience Announces FDA Clearance of MeRT® for PTSD
Belfast health-tech company Neurovalens has received ‘de novo’ approval from the US FDA for its prescribed treatment for symptoms…
Military veterans will have first access to Modius Spero vestibular stimulation
It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use…
News and commentary from the world of neurology and neuroscience
ReST Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for RST-101 for the Early Treatment…
